RBM45 and Alzheimer disease: Instead, we found that the presence of RBM45 nuclear inclusions correlated with disruption of the normal distribution and immunoreactivity of SAFB in ALS, FTLD, and AD (Figs. 7 and 8), similar to our results with chronic CdSO4 treatment (Fig. S7).